Older renal cell cancer patients experience increased rates of venous thromboembolic events: a retrospective cohort study of SEER-Medicare data

被引:0
作者
Alexandra Connelly-Frost
Sumitra Shantakumar
Monica G Kobayashi
Haojie Li
Li Li
机构
[1] Frost Consulting,
[2] Epidemiologic Research and Grant Writing,undefined
[3] Department of Worldwide Epidemiology,undefined
[4] Research and Development,undefined
[5] GlaxoSmithKline,undefined
[6] Department of Worldwide Epidemiology,undefined
[7] Research and Development,undefined
[8] GlaxoSmithKline,undefined
来源
BMC Cancer | / 13卷
关键词
Venous thromboembolism; Renal cell carcinoma; Incidence; Co-morbidity; Pulmonary embolism; Deep vein thrombosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 103 条
[1]  
Sorensen HT(2000)Prognosis of cancers associated with venous thromboembolism N Engl J Med 343 1846-1850
[2]  
Mellemkjaer L(2006)Incidence of venous thromboembolism and its effect on survival among patients with common cancers Arch Intern Med 166 458-464
[3]  
Olsen JH(2007)Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy J Thromb Haemost 5 632-634
[4]  
Baron JA(2003)Venous thromboembolism and cancer: risks and outcomes Circulation 107 I17-I21
[5]  
Chew HK(2006)A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project Ann Surg 243 89-95
[6]  
Wun T(2006)Incidence of venous thrombosis in a large cohort of 66,329 cancer patients: results of a record linkage study J Thromb Haemost 4 529-535
[7]  
Harvey D(2006)Thromboembolism in hospitalized neutropenic cancer patients J Clin Oncol 24 484-490
[8]  
Zhou H(2007)Frequency, risk factors, and trends for venous thromboembolism among hospitalized cancer patients Cancer 110 2339-2346
[9]  
White RH(2008)Development and validation of a predictive model for chemotherapy-associated thrombosis Blood 111 4902-4907
[10]  
Khorana AA(1999)Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data Medicine (Baltimore) 78 285-291